Kendall Marcus
Company: FDA
Job title: Director Dermatology & Dentistry
Seminars:
FDA Perspective on JAK Inhibitor Development & Dermatologic Disorders 2:15 pm
day: Day Two
FDA Perspective on JAK Inhibitor Development & Dermatologic Disorders 2:15 pm
Considering what clinical endpoints the FDA will accept across multiple disciplines within JAK inhibitor drug development to accelerate delivery to market Q&A Time: An extended 15 minute session post presentation to alleviate all JAK inhibitor pipeline queries and save labor downstreamRead more
day: Day Two